LAIR1 and glioma: In glioma, we investigated that LAIR‐1 overexpression was interrelated with clinicopathologic features such as grade, IDH status, 1p/19q non‐co‐deletion, and MGMT, suggesting that LAIR‐1 overexpression participates a role in the malignant behavior of glioma.